Cancer
Owlstone Medical Recruits First Patient in Phase 2 Clinical Trial for the Early Detection of Lung Cancer through Breath Biopsy®
10 Oct 2023
Read More
Breath Biopsy
Owlstone Medical Announces Advancements in Breath Biopsy Platform Including Launch of Next Generation ReCIVA Breath Sampler and CASPER Portable Air Supply
Read More
15 Sep 2019
Breath Biopsy
Owlstone Medical Announces a Novel Approach to Breath-Based Testing for Investigation of the Onset, Progression, and Treatment of Disease
Read More
18 Jun 2019
Breath Biopsy
Owlstone Medical and the International Association of Heat and Frost Insulators and Allied Workers Partner to Identify Breath Biomarkers for the Early Detection of Malignant Mesothelioma
Read More
5 Jun 2019
Breath Biopsy
Owlstone Medical Enters into a Strategic Collaboration with Actelion to Develop a Breath-Based Test to Help Facilitate Early Detection of Pulmonary Hypertension
Read More
20 May 2019
Breath Biopsy
University of Manchester and Owlstone Medical Partner on £250,000 Grant from Asthma UK and Innovate UK for Asthma Diagnostic Development
Read More
7 Mar 2019
Breath Biopsy
Owlstone Medical Partners with Shanghai Renji Hospital to Pioneer Breath Biopsy Lung Cancer Trial in China
Read More
20 Feb 2019
Breath Biopsy
Clinical Trial Launches to Develop Breath Test for Multiple Cancers
Read More
3 Jan 2019
Company Updates
Owlstone Medical Named in Top 10 Disruptors to Watch by Sunday Times
Read More
3 Dec 2018
Company Updates
Owlstone Medical Appoints Dr Richard A Yost to Scientific Advisory Board
Read More
10 Oct 2018
Company Updates
Owlstone Medical Completes $50 Million USD (c.£38 Million GBP) Financing Round
Read More
7 Oct 2018
Company Updates
Owlstone Medical Appoints Dr Andy Richards CBE to Board of Directors
Read More
14 Sep 2018
Breath Biopsy
Breath Biopsy platform scoops the UK’s most prestigious award for engineering innovation
Read More
27 Jul 2018

Talk to us about your biomarker research and how Breath Biopsy could help.